Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Takotsubo syndrome due to occupational stress in a physician.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same author
Three-dimensional micro-CT analysis of vascular remodeling and vascular pruning in pulmonary arterial hypertension.
The European respiratory journal·2026
Same author
Safety and efficacy of a dedicated pulmonary thromboendarterectomy fellowship: The Royal Papworth experience at a high-volume center.
The Journal of thoracic and cardiovascular surgery·2026
Related Experiment Video
Updated: Jun 14, 2025
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
12.2K
Chronic thromboembolic pulmonary disease.
Nick H Kim1, Andrea M D'Armini2, Marion Delcroix3
1Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, La Jolla, CA, USA.
The European Respiratory Journal
|August 29, 2024
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is a treatable condition often diagnosed late. Prompt evaluation and multidisciplinary care, including mechanical therapies, significantly improve patient survival rates.
More Related Videos
Area of Science:
- Cardiology
- Pulmonary Medicine
- Vascular Surgery
Background:
- Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious complication of pulmonary embolism.
- It results from unresolved clots causing mechanical obstruction and microvascular disease, increasing pulmonary vascular resistance.
- Delayed diagnosis is common, hindering timely and effective treatment.
Purpose of the Study:
- To highlight the diagnostic challenges and treatment strategies for CTEPH.
- To emphasize the importance of expert centers and multidisciplinary decision-making.
- To review the efficacy of current therapeutic interventions.
Main Methods:
- Review of diagnostic modalities, focusing on high-quality imaging.
- Assessment of patient operability for surgical or interventional procedures.
- Evaluation of outcomes associated with various treatment approaches.
Main Results:
- Accurate diagnosis is often delayed, impacting treatment planning.
- Mechanical therapies, including pulmonary endarterectomy and balloon pulmonary angioplasty, offer the best symptom and survival improvements.
- Multimodal therapies achieve excellent outcomes, with 3-year survival exceeding 90%.
Conclusions:
- Early and accurate diagnosis of CTEPH is crucial.
- Referral to expert centers for multidisciplinary evaluation is essential for optimal management.
- Advanced treatment strategies, particularly mechanical therapies, lead to significantly improved long-term survival in CTEPH patients.